Quantifying unnecessary normal tissue complication risks due to suboptimal planning: A secondary study of RTOG 0126

International Journal of Radiation Oncology Biology Physics

Volumn 92, Issue 2, 2015, Pages 228-235

  Moore, Kevin L ^a   Schmidt, Rachel ^b   Moiseenko, Vitali ^a   Olsen, Lindsey A ^c   Tan, Jun ^c   Xiao, Ying ^d   Galvin, James ^d   Pugh, Stephanie ^e   Seider, Michael J ^f   Dicker, Adam P ^d   Bosch, Walter ^c   Michalski, Jeff ^c   Mutic, Sasa ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b FORT HAYS STATE UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^e NRG ONCOLOGY STATISTICS AND DATA MANAGEMENT CENTER   (United States)

^f AKRON CITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KNOWLEDGE BASED SYSTEMS; RADIOTHERAPY; TISSUE; TOXICITY;

DOSE-VOLUME HISTOGRAMS; INTENSITY-MODULATED RADIATION THERAPY; KNOWLEDGE-BASED METHODS; METHODS AND MATERIALS; NORMAL TISSUE COMPLICATION PROBABILITIES; QUALITY VARIATION; RADIATION THERAPY ONCOLOGY GROUPS; STATISTICAL POWER;

RISKS;

ACCURACY; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; ORGANS AT RISK; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIATION INJURY; RADIOTHERAPY PLANNING SYSTEM; RANDOMIZED CONTROLLED TRIAL; RECTUM DISEASE; STATISTICAL SIGNIFICANCE; ADVERSE EFFECTS; BENCHMARKING; CLINICAL TRIAL; CONSERVATIVE TREATMENT; HEALTH CARE QUALITY; MULTICENTER STUDY; PROCEDURES; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIATION RESPONSE; RECTUM; RISK ASSESSMENT; STANDARDS; STATISTICAL MODEL;

BENCHMARKING; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MODELS, STATISTICAL; ORGAN SPARING TREATMENTS; ORGANS AT RISK; PROSTATIC NEOPLASMS; QUALITY OF HEALTH CARE; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RISK ASSESSMENT;

EID: 84928938597     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.01.046     Document Type: Article

References (21)

1. K.L. Moore, R.S. Brame, and D.A. Low Experience-based quality control of clinical intensity-modulated radiotherapy planning Int J Radiat Oncol Biol Phys 81 2011 545 551
2. B. Wu, F. Ricchetti, and G. Sanguineti Patient geometry-driven information retrieval for IMRT treatment plan quality control Med Phys 36 2009 5497 5505
3. B.E. Nelms, G. Robinson, and J. Markham Variation in external beam treatment plan quality: An inter-institutional study of planners and planning systems Pract Radiat Oncol 2 2012 296 305
4. L.J. Peters, B. O'Sullivan, and J. Giralt Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 0202 J Clin Oncol 28 2010 2996 3001
5. T.J. Fitzgerald What we have learned: The impact of quality from a clinical trials perspective Semin Radiat Oncol 22 2012 18 28
6. R.A. Abrams, K.A. Winter, and W.F. Regine Failure to adhere to protocol specified RT guidelines was associated with decreased survival in RTOG 9704 - A phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas Int J Radiat Oncol Biol Phys 82 2012 809 816
7. A. Fairchild, W. Straube, and F. Laurie Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review Int J Radiat Oncol Biol Phys 87 2013 246 260
8. N. Ohri, X. Shen, and A.P. Dicker Radiotherapy protocol deviations and clinical outcomes: A meta-analysis of cooperative group clinical trials J Natl Cancer Inst 105 2013 387 393
9. L.M. Appenzoller, J.M. Michalski, and W.L. Thorstad Predicting dose-volume histograms for organs-at-risk in IMRT planning Med Phys 39 2012 7446
10. X. Zhu, Y. Ge, and T. Li A planning quality evaluation tool for prostate adaptive IMRT based on machine learning Med Phys 38 2011 719 726
11. B. Wu, F. Ricchetti, and G. Sanguineti Data-driven approach to generating achievable dose-volume histogram objectives in intensity-modulated radiotherapy planning Int J Radiat Oncol Biol Phys 79 2011 1241 1247
12. B. Wu, T. McNutt, and M. Zahurak Fully automated simultaneous integrated boosted-intensity modulated radiation therapy treatment planning is feasible for head-and-neck cancer: A prospective clinical study Int J Radiat Oncol Biol Phys 84 2012 e647 e653
13. J.M. Michalski, Y. Yan, and D. Watkins-Bruner Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial Int J Radiat Oncol Biol Phys 87 2013 932 938
14. Michalski JM. Unpublished presentation at the plenary session. 56th Annual Meeting of the American Society for Radiation Oncology. San Francisco, CA, 2014.
15. S.L. Tucker, L. Dong, and J.M. Michalski Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from Radiation Therapy Oncology Group protocol 94-06 Int J Radiat Oncol Biol Phys 84 2012 390 395
16. G. Fellin, T. Rancati, and C. Fiorino Long term rectal function after high-dose prostatecancer radiotherapy: Results from a prospective cohort study Radiother Oncol 110 2014 272 277
17. J.M. Michalski, H. Gay, and A. Jackson Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 S123 S129
18. S.A. Roberts, and J.H. Hendry The delay before onset of accelerated tumour cell repopulation during radiotherapy: A direct maximum-likelihood analysis of a collection of worldwide tumour-control data Radiother Oncol 29 1993 69 74
19. A.S. Viswanathan, E.D. Yorke, and L.B. Marks Radiation dose-volume effects of the urinary bladder Int J Radiat Oncol Biol Phys 76 2010 S116 S122
20. S.F. Petit, B. Wu, and M. Kazhdan Increased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinoma Radiother Oncol 102 2012 38 44
21. L. Yuan, Y. Ge, and W.R. Lee Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans Med Phys 39 2012 6868 6878